Today, resistance developed by bacteria to common antibiotics that were otherwise regarded as effective is posing a serious challenge. It is believed that without any different efforts, this perennial problem will undermine all the ongoing efforts in antibiotic discovery and therapy development. In Nigeria, antibiotics are frequently prescribed in hospitals. However, issues like multidrug resistance (MDR) and inappropriate use and misuse of antibiotics, including incorrect dosages and use of broad-spectrum antibiotics for targeted infections, have precipitated the rise of MDR bacteria. Consequently, this leads to higher healthcare costs, mainly due to prolonged hospital stays and additional medications as well as increased patient mortality. The prospects of artificial intelligence (AI)-enabled antibiotic prescribing hold significant promise in transforming the current health-care practices. AI has the potential to enhance the precision and efficiency of antibiotic treatment through advanced algorithms and data analytics. This technology can contribute to improved diagnostic accuracy, providing real-time clinical support, optimizing dosage recommendations, personalized treatment plans, and streamlined antimicrobial stewardship, ultimately aiding the global fight against antibiotic resistance and optimizing patient outcomes. The integration of AI in antibiotic prescribing reflects a cutting-edge approach with the potential to revolutionize how antibiotics are prescribed to address challenges in antimicrobial stewardship, clinical decision-making, and combating antibiotic resistance. One of the key impediments to integrating AI into Nigeria’s health-care system is budgetary constraints. Addressing these constraints through strategic investments, improved budgetary allocation to research and development, and leveraging the opportunities presented by AI technologies can significantly enhance antibiotic prescribing and health-care practices, leading to improved public health outcomes.